Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Capochiani · SciRah

Researcher profile · Semantic Scholar

E. Capochiani

Share profile

E. Capochiani — researcher profile on SciRah

h-index: 12
Works: 39
Citations: 877

Most-cited papers

Hepatitis C virus infection in patients with non‐Hodgkin's lymphoma
C. Ferri, F. Caracciolo, A. L. Zignego, L. La Civita +8 more
1994British Journal of Haematology273 citations Open access
Semantic Scholar
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)
M. Rummel, T. Kim, F. Aversa, W. Brugger +7 more
2016Annals of Oncology148 citations Open access
Semantic Scholar
Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome
M. A. Aloe Spiriti, R. Latagliata, P. Niscola, A. Cortelezzi +21 more
2005Annals of Hematology117 citations
Semantic Scholar
Interferon-α in the idiopathic hypereosinophilic syndrome: consideration of five cases
S. Ceretelli, E. Capochiani, M. Petrini
1998Annals of Hematology52 citations
Semantic Scholar
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol
E. Capochiani, B. Frediani, G. Iervasi, A. Paolicchi +14 more
2020Frontiers in Medicine50 citations Open access
Semantic Scholar
Paraneoplastic choreic syndrome during non‐Hodgkin's lymphoma
A. Nuti, R. Ceravolo, S. Salvetti, G. Gambaccini +2 more
2000Movement Disorders30 citations
Semantic Scholar
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
A. Gozzetti, E. Capochiani, M. Bocchia
2020Leukemia25 citations Open access
Semantic Scholar
Real‐world experience with decitabine as a first‐line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy
M. Bocchia, A. Candoni, E. Borlenghi, M. Defina +38 more
2019Hematological Oncology25 citations Open access
Semantic Scholar
Motility of rhG‐CSF‐induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis
A. Azzará, G. Carulli, A. Rizzuti‐Gullaci, S. Minnucci +2 more
1996British Journal of Haematology21 citations Open access
Semantic Scholar
Recovering from chronic myeloid leukemia: the patients’ perspective seen through the lens of narrative medicine
G. Graffigna, I. Cecchini, M. Breccia, E. Capochiani +16 more
2017Quality of Life Research20 citations
Semantic Scholar
Interferon-alpha in the idiopathic hypereosinophilic syndrome: consideration of five cases.
S. Ceretelli, E. Capochiani, M. Petrini
1998Annals of Hematology20 citations
Semantic Scholar
Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute.
Simon Rule, J. Briones, Rodney Smith, Oklota C Theodore +4 more
2014Value in Health15 citations Open access
Semantic Scholar
Alternating chemotherapy regimen (P‐VABEC) for intermediate and high‐grade non‐Hodgkin's lymphoma of the middle aged and elderly
F. Caracciolo, M. Petrini, E. Capochiani, F. Papineschi +2 more
1994Hematological Oncology12 citations
Semantic Scholar
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis
M. Breccia, G. Graffigna, S. Galimberti, A. Iurlo +23 more
2016Supportive Care in Cancer11 citations Open access
Semantic Scholar
JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy
A. Vannucchi, A. Mortara, A. D'Alessio, M. Morelli +20 more
2021Journal of Clinical Medicine8 citations Open access
Semantic Scholar
Chronic Myeloid Leukemia Patient’s Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial
Lidia Borghi, S. Galimberti, C. Baratè, M. Bonifacio +12 more
2019Frontiers in Psychology8 citations Open access
Semantic Scholar
A new effective treatment for indolent lymphoma: a pilot study with fludarabine, idarubicin and prednisone combination (FLIDA)
F. Caracciolo, E. Capochiani, F. Papineschi, M. Petrini
1997Hematological Oncology6 citations
Semantic Scholar
IELSG-38: A Phase II Study of Chlorambucil in Combination with Rituximab Followed By Maintenance Therapy with Subcutaneous Rituximab in Patients with Extranodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT)
A. Stathis, A. Gregorini, R. Gressin, L. Orsucci +26 more
20175 citations
Semantic Scholar
Prefmab: Final Analysis of Patient Preference for Subcutaneous Versus Intravenous Rituximab in Previously Untreated CD20+ Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
M. Rummel, T. Kim, C. Plenteda, E. Capochiani +4 more
20155 citations Open access
Semantic Scholar
A Prospective Cross-Sectional Study on the Comparison of Ultrasound Assessment vs. Palpation in Chronic Lymphocytic Leukemia Patients in the Era of Targeted Therapy
E. Benedetti, Fabrizio Mavilia, C. Baratè, E. Bramanti +7 more
2022Journal of Clinical Medicine4 citations Open access
Semantic Scholar
PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A 2‐YEAR SUBCUTANEOUS RITUXIMAB MAINTENANCE IN MALT LYMPHOMA PATIENTS (IELSG38)
M. Pirosa, L. Orsucci, P. Feugier, M. Tani +42 more
2021Hematological Oncology4 citations Open access
Semantic Scholar
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant)
V. Sammartano, Adele Santoni, B. Frediani, A. Sicuranza +4 more
2020Leukemia and Lymphoma3 citations
Semantic Scholar
Prefmab: Final Analysis Of Patient Satisfaction With Subcutaneous Versus Intravenous Rituximab In Previously Untreated Cd20+ Diffuse Large B-Cell Lymphoma Or Follicular Lymphoma.
M. Rummel, T. Kim, Caterina Plenteda, E. Capochiani +4 more
2015Value in Health3 citations Open access
Semantic Scholar
Heart involvement in T cell lymphoma through hypereosinophilic syndrome: a common complication of a rare condition.
A. Genovesi-Ebert, M. Lombardi, E. Capochiani, U. Simi +6 more
2005Journal of Cardiovascular Magnetic Resonance3 citations
Semantic Scholar
Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region
M. Bocchia, A. Bosi, E. Capochiani, S. Ciolli +6 more
2020Farmeconomia: Health Economics and Therapeutic Pathways2 citations Open access
Semantic Scholar
Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: Evaluation by computer‐assisted image analysis
A. Azzará, G. Carulli, A. Rizzuti‐Gullaci, E. Capochiani +1 more
2001American journal of hematology/oncology2 citations Open access
Semantic Scholar
Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease
E. Benedetti, C. Baratè, Fabrizio Mavilia, E. Bramanti +9 more
2023Journal of Clinical Medicine1 citations Open access
Semantic Scholar
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy
Lidia Borghi, G. Rosti, A. Maggi, M. Breccia +22 more
2021Frontiers in Oncology1 citations Open access
Semantic Scholar
Renal carcinoma in two patients with poor prognosis NHL treated with high-dose chemotherapy and peripheral stem cell autotransplantation
F. Caracciolo, F. Papineschi, E. Benedetti, E. Capochiani +8 more
19991 citations
Semantic Scholar
Unusual presentation of extranodal diffuse large B-cell lymphoma in a solid-organ recipient during long-term immunosuppressive treatment
C. Camerini, Emanuela Sant'Antonio, A. Ginori, M. Pellegri +7 more
2021Tumori0 citations
Semantic Scholar
Author response for "REAL‐WORD EXPERIENCE WITH DECITABINE AS A FIRST‐LINE TREATMENT IN 306 ELDERLY ACUTE MYELOID LEUKAEMIA PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY"
M. Bocchia, A. Candoni, E. Borlenghi, M. Defina +38 more
20190 citations
Semantic Scholar
Efficacy and Safety of Subcutaneous or Intravenous Administration of Rituximab in Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Final Results of the Randomized, Open-Label, Crossover, PrefMab Study
M. Rummel, T. Kim, F. Aversa, W. Brugger +9 more
20170 citations
Semantic Scholar
First Line Treatment with Bendamustine in Selected Non Hodgkin's Lymphoma Patients: Prospective Experience in Tuscany Region
L. Rigacci, Benedetta Puccini, Roberta Della Seta, E. Capochiani +9 more
20140 citations
Semantic Scholar
Pegfilgrastim to support chop-r chemotherapy administered every 14 days in the patients (pts) with aggressive b-cell non-hodgkin’s lymphoma (NHL)
S. Cupini, E. Capochiani, S. Bursi, L. Landi +15 more
20070 citations
Semantic Scholar
Autologous transplantation with Philadelphia chromosome negative stem cells mobilized in first chronic phase-chronic myeloid leukaemia
F. Papineschi, F. Caracciolo, E. Benedetti, S. Galimberti +8 more
19990 citations
Semantic Scholar
178 Oral idarubicin administration as monochemotherapy in myelodisplastic syndromes
M. Petrini, E. Capochiani, F. Caracciolo, S. Galimberti +2 more
19970 citations
Semantic Scholar
62 P - CIP regimen as consolidation therapy after P-VABEC in aggressive NHL of the elderly
F. Caracciolo, M. Petrini, F. Papineschi, E. Capochiani +4 more
19960 citations
Semantic Scholar
ProMICE-CytaBOM chemotherapy in aggressive NHL. A preliminary report
F. Caracciolo, M. Petrini, E. Capochiani, F. Papineschi +2 more
19940 citations
Semantic Scholar
Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Malignancies: A Review of the Scientific Rationale and Clinical Development Development
Andrew J Davies, C. Berge, A. Boehnke, Anjum Dadabhoy +126 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Petrini×12
Invite
M. Petrini — researcher profile on SciRah
S. Galimberti×9
Invite
S. Galimberti — researcher profile on SciRah
F. Caracciolo×8
Invite
F. Caracciolo — researcher profile on SciRah
F. Simonetti×7
Invite
F. Simonetti — researcher profile on SciRah

×7

Invite

M. Bocchia — researcher profile on SciRah

F. Papineschi×6

Invite

F. Papineschi — researcher profile on SciRah

Rodney Smith×5

Invite

Rodney Smith — researcher profile on SciRah

Invite

A. Azzará — researcher profile on SciRah

Invite

G. Carulli — researcher profile on SciRah

Invite

M. Rummel — researcher profile on SciRah

Invite

A. Iurlo — researcher profile on SciRah

Invite

C. Plenteda — researcher profile on SciRah